Soleno Therapeutics, Inc. · NASDAQ:SLNO

Adage Capital Management, L.P. reported a 9.58% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 12, 2025

Adage Capital Management, L.P. reported a 9.58% stake in Soleno Therapeutics, Inc., 4,392,696 shares, as a passive investor on Mar 31, 2025. Filed May 12, 2025 (Schedule 13G/A).

Stake
9.58%
Shares
4,392,696
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Adage Capital Management, L.P.9.58%4,392,696
Robert Atchinson9.58%4,392,696
Phillip Gross9.58%4,392,696

Source

View original at SEC

Related